Northern Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $728M | Sell |
941,941
-2,992
| -0.3% | -$2.29M | 0.1% | 192 |
|
|
2025
Q4 | $729M | Sell |
944,933
-39,859
| -4% | -$27.1M | 0.09% | 188 |
|
|
2025
Q3 | $554M | Buy |
984,792
+26,223
| +3% | +$14.8M | 0.07% | 235 |
|
|
2025
Q2 | $503M | Sell |
958,569
-43,181
| -4% | -$24.1M | 0.07% | 245 |
|
|
2025
Q1 | $635M | Sell |
1,001,750
-53,079
| -5% | -$36.5M | 0.09% | 197 |
|
|
2024
Q4 | $751M | Buy |
1,054,829
+136,184
| +15% | +$114M | 0.11% | 172 |
|
|
2024
Q3 | $966M | Sell |
918,645
-48,081
| -5% | -$53.5M | 0.16% | 121 |
|
|
2024
Q2 | $1.02B | Sell |
966,726
-24,739
| -2% | -$24M | 0.17% | 108 |
|
|
2024
Q1 | $954M | Sell |
991,465
-54,943
| -5% | -$52.2M | 0.16% | 121 |
|
|
2023
Q4 | $919M | Sell |
1,046,408
-20,802
| -2% | -$17.1M | 0.17% | 121 |
|
|
2023
Q3 | $878M | Buy |
1,067,210
+34,326
| +3% | +$27M | 0.17% | 115 |
|
|
2023
Q2 | $742M | Sell |
1,032,884
-121,689
| -11% | -$93.8M | 0.14% | 133 |
|
|
2023
Q1 | $949M | Sell |
1,154,573
-9,439
| -0.8% | -$7.12M | 0.19% | 104 |
|
|
2022
Q4 | $840M | Sell |
1,164,012
-24,785
| -2% | -$18.3M | 0.18% | 113 |
|
|
2022
Q3 | $819M | Sell |
1,188,797
-10,365
| -0.9% | -$6.52M | 0.19% | 106 |
|
|
2022
Q2 | $709M | Sell |
1,199,162
-1,952
| -0.2% | -$1.27M | 0.15% | 129 |
|
|
2022
Q1 | $839M | Sell |
1,201,114
-2,212
| -0.2% | -$1.4M | 0.15% | 129 |
|
|
2021
Q4 | $760M | Buy |
1,203,326
+3,291
| +0.3% | +$2.02M | 0.12% | 149 |
|
|
2021
Q3 | $726M | Buy |
1,200,035
+38,532
| +3% | +$23.9M | 0.13% | 141 |
|
|
2021
Q2 | $649M | Sell |
1,161,503
-15,589
| -1% | -$7.9M | 0.11% | 157 |
|
|
2021
Q1 | $557M | Sell |
1,177,092
-65,883
| -5% | -$32.1M | 0.1% | 176 |
|
|
2020
Q4 | $600M | Sell |
1,242,975
-43,727
| -3% | -$23.6M | 0.12% | 158 |
|
|
2020
Q3 | $720M | Buy |
1,286,702
+61,531
| +5% | +$37.3M | 0.16% | 120 |
|
|
2020
Q2 | $764M | Buy |
1,225,171
+264,126
| +27% | +$150M | 0.18% | 103 |
|
|
2020
Q1 | $469M | Buy |
961,045
+14,449
| +2% | +$5.96M | 0.13% | 147 |
|
|
2019
Q4 | $355M | Buy |
946,596
+4,771
| +0.5% | +$1.61M | 0.08% | 240 |
|
|
2019
Q3 | $261M | Sell |
941,825
-36,693
| -4% | -$10.9M | 0.06% | 294 |
|
|
2019
Q2 | $306M | Buy |
978,518
+5,530
| +0.6% | +$1.84M | 0.07% | 258 |
|
|
2019
Q1 | $400M | Buy |
972,988
+20,218
| +2% | +$8.33M | 0.1% | 202 |
|
|
2018
Q4 | $356M | Buy |
952,770
+22,468
| +2% | +$8.22M | 0.1% | 196 |
|
|
2018
Q3 | $376M | Sell |
930,302
-3,943
| -0.4% | -$1.5M | 0.09% | 212 |
|
|
2018
Q2 | $322M | Buy |
934,245
+17,931
| +2% | +$5.61M | 0.08% | 234 |
|
|
2018
Q1 | $316M | Sell |
916,314
-18,895
| -2% | -$6.57M | 0.08% | 245 |
|
|
2017
Q4 | $352M | Sell |
935,209
-22,751
| -2% | -$9.21M | 0.09% | 226 |
|
|
2017
Q3 | $428M | Buy |
957,960
+26,677
| +3% | +$12.7M | 0.11% | 184 |
|
|
2017
Q2 | $457M | Buy |
931,283
+6,977
| +0.8% | +$3.05M | 0.13% | 156 |
|
|
2017
Q1 | $358M | Buy |
924,306
+29,484
| +3% | +$10.9M | 0.1% | 193 |
|
|
2016
Q4 | $328M | Sell |
894,822
-28,866
| -3% | -$11M | 0.1% | 199 |
|
|
2016
Q3 | $371M | Buy |
923,688
+157
| +0% | +$63K | 0.12% | 177 |
|
|
2016
Q2 | $323M | Sell |
923,531
-105
| -0% | -$40.4K | 0.1% | 196 |
|
|
2016
Q1 | $338M | Sell |
923,636
-3,248
| -0.4% | -$1.34M | 0.11% | 182 |
|
|
2015
Q4 | $503M | Sell |
926,884
-37,488
| -4% | -$20.3M | 0.17% | 114 |
|
|
2015
Q3 | $449M | Sell |
964,372
-26,046
| -3% | -$14M | 0.15% | 132 |
|
|
2015
Q2 | $505M | Buy |
990,418
+64,211
| +7% | +$31.3M | 0.15% | 134 |
|
|
2015
Q1 | $418M | Sell |
926,207
-25,358
| -3% | -$10.7M | 0.13% | 165 |
|
|
2014
Q4 | $390M | Sell |
951,565
-9,573
| -1% | -$3.76M | 0.12% | 174 |
|
|
2014
Q3 | $347M | Sell |
961,138
-58,548
| -6% | -$19.6M | 0.11% | 177 |
|
|
2014
Q2 | $288M | Sell |
1,019,686
-43,055
| -4% | -$12.8M | 0.09% | 215 |
|
|
2014
Q1 | $319M | Buy |
1,062,741
+17,417
| +2% | +$5.37M | 0.1% | 192 |
|
|
2013
Q4 | $288M | Buy |
1,045,324
+40,607
| +4% | +$11.7M | 0.09% | 209 |
|
|
2013
Q3 | $314M | Sell |
1,004,717
-10,501
| -1% | -$2.76M | 0.11% | 180 |
|
|
2013
Q2 | $228M | Buy |
+1,015,218
| New | +$236M | 0.08% | 235 |
|
Other funds holding REGN
VCM
N
Northern Trust's REGN Position: Q1 2026 in Review
Northern Trust reduced its Regeneron Pharmaceuticals (REGN) stake by 0.32% in Q1 2026, selling an estimated $2.29M and leaving 941,941 shares worth $728M. The position accounts for 0.1% of the portfolio, ranked #192.
Northern Trust first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Northern Trust held 941,941 shares of Regeneron Pharmaceuticals worth $728M as of Q1 2026.
- Northern Trust sold 2,992 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.29M.
- Regeneron Pharmaceuticals made up 0.1% of Northern Trust's portfolio in Q1 2026, its #192 holding.
- Northern Trust first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Regeneron Pharmaceuticals position peaked at $1.02B in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.